Amazon’s Ophthalmic Drug Products Program Policy sets out the steps required to verify the safety and quality of eye-care products sold on its platform. The process involves several key stages:
- Product testing and review: you partner with us to conduct the necessary testing for your specific ophthalmic product type. This ensures your product meets Amazon’s safety and quality requirements
- Good Manufacturing Practice (GMP) certification: you provide GMP certificates from your manufacturer to confirm production in facilities that follow recognized quality manufacturing standards.
- Label verification and product testing: we review your product labels, documentation, and testing results to ensure they meet Amazon’s OTC ophthalmic product standards.
The verification itself follows a two-phase structure:
Phase 1: label verification
We verify that your product labels comply with 21 CFR 201 Subpart C and 21 CFR 349, and confirm that your manufacturer meets cGMP 210/211, NSF 455-4, or equivalent standards. Label approval is required before moving on to the next phase.
Phase 2: product sterility testing
Once labels are approved, we perform sterility and tamper-evident packaging testing under cGMP conditions to ensure your products are safe for consumer use.
This two-phase approach helps you avoid unnecessary costs by ensuring products that do not pass label verification are not tested further. Once verification is complete, we report a ‘Pass’ or ‘Fail’ status to you and to Amazon.